This segment focuses on the discovery and development of small molecule therapeutics for the treatment of various cancers. Research and development activities include identifying and validating novel drug targets, designing and synthesizing drug candidates, conducting preclinical studies, and managing clinical trials. The company utilizes its expertise in epigenetics to develop therapies that address unmet medical needs in oncology. This includes targeting specific pathways involved in cancer development and drug resistance. The patient impact is significant, aiming to improve outcomes and quality of life for cancer patients. Market positioning is based on innovative approaches to cancer treatment, with competitive advantages in epigenetic drug discovery. Future opportunities include expanding the pipeline and exploring new therapeutic areas. Regulatory and clinical aspects involve navigating FDA approval processes and conducting clinical trials to demonstrate safety and efficacy. Partnerships and collaborations, such as the one with Genentech, are crucial for advancing research and development efforts.

This segment is dedicated to developing therapeutics for hematological malignancies and disorders. Research and development efforts are focused on identifying and validating targets within hematological pathways, designing and synthesizing small molecule therapeutics, and conducting preclinical and clinical trials. The company leverages its expertise in epigenetics to develop therapies that address unmet medical needs in hematology, such as myelofibrosis. The goal is to improve patient outcomes and quality of life for individuals with hematological disorders. Market positioning is based on innovative approaches to hematological disease treatment, with competitive advantages in epigenetic drug discovery. Future opportunities include expanding the pipeline and exploring new therapeutic areas. Regulatory and clinical aspects involve navigating FDA approval processes and conducting clinical trials to demonstrate safety and efficacy. Partnerships and collaborations are essential for advancing research and development efforts in this segment.